Journal
MEDICINA CLINICA
Volume 144, Issue 5, Pages 223-229Publisher
ELSEVIER ESPANA SLU
DOI: 10.1016/j.medcli.2014.01.029
Keywords
Acute T-cell lymphoblastic leukemia; Molecular markers; Biology; Treatment
Categories
Ask authors/readers for more resources
Acute lymphoblastic leukemia (ALL) is the most common cancer in children and the main cause of morbidity among childhood blood disorders. There are 2 subtypes according to the affected lymphoid progenitor: B-ALL and T-ALL. The T-ALL is the less common and, although historically was associated with poor prognosis in both adults and children, at present, treatment outcomes do not differ significantly between the 2 types of ALL The T-ALL subtype is the most complex and heterogeneous at the genetic level and currently the one with less new therapeutic alternatives available. This trend is changing thanks to the remarkable progress upon understanding its biology. This review summarizes the most recent and important biological findings in T-ALL and their possible therapeutic implications. (C) 2013 Elsevier Espana, S.L.U. All rights reserved.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available